Palobiofarma S.L. is pleased to announce the “last patient last visit” of the Phase II trial investigating the safety and preliminary efficacy of PBF-680 in moderate to severe COPD patients.
Read moreLaminar Pharma opens a new financing round of up to seven million euros. The objective is to finish financing the development of its drug LAM561 against the most aggressive and common brain cancer, gl...
Read moreEl Instituto de Investigación Sanitaria INCLIVA, del Hospital Clínico Universitario de València, ha impulsado un ensayo clínico para evaluar la seguridad y la tolerabilidad del anticuerpo blinatum...
Read moreTheriva™ Biologics has announced the presentation of preclinical data demonstrating enhanced anti-tumor effects in human pancreatic cancer xenograft-bearing mice treated with lead product candidate...
Read moreInvestigadores del Cima Universidad de Navarra constatan que la combinación de dos fármacos, ya conocidos, abre el camino a posibles ensayos clínicos para combatir los gliomas difusos de línea med...
Read moreThis article explores the current state of pharmaceutical innovation, predicts future trends, and discusses the role of artificial intelligence in shaping the industry. Furthermore, it highlights the ...
Read moreA clinical trial of CAR-T therapies has brought the word curable almost within touching distance for multiple myeloma, the second most common blood cancer in the world, thus increasing hope and qualit...
Read moreMikrobiomik has given CaixaBank CIB the exclusive mandate to assist in the search for potential investors for this round of capital, aimed primarily at Venture Capital, both national and international...
Read moreMemo Therapeutics, a late-stage biotech company developing a best-in-class BKV-neutralizing antibody for BKV infection in kidney transplantation, today announces that it has successfully raised CHF 20...
Read moreMetabolomics has the potential to revolutionize drug discovery by enabling researchers to identify biomarkers, understand disease pathways, and develop personalized treatments tailored to individual p...
Read moreTres expertos ponen en cuestión el estudio, realizado por 31 investigadores de diversas universidades y hospitales chinos, que ha supuesto la aprobación para uso médico en dicho país de Simnotrelv...
Read moreAlphaFold3 predice la estructura e interacciones de proteínas con otras moléculas como el ADN y el ARN.
Read more